| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/18/2008 | EP1932523A1 Adhesive preparation containing bisoprolol |
| 06/18/2008 | EP1932522A1 Therapeutic agent for liver disease containing 2-amino-1,3-propanediol derivative as active ingredient and therapeutic method for liver disease |
| 06/18/2008 | EP1932521A1 Nutritional supplement composition for treatment of ocular diseases |
| 06/18/2008 | EP1932520A1 Nutritional supplement composition for treatment of ocular diseases |
| 06/18/2008 | EP1932518A1 Statin containing compositions for treatment of cancer |
| 06/18/2008 | EP1932517A2 Liposomes containing a polyphenol derivative such as caffeic acid and a method of post-loading thereof |
| 06/18/2008 | EP1932516A1 Anti-inflammatory compounds containing compositions for treatment of cancer |
| 06/18/2008 | EP1932425A2 Powder disinfectant for the teats of dairy animals |
| 06/18/2008 | EP1931806A2 Pkr activation via hybridization chain reaction |
| 06/18/2008 | EP1931797A2 Pde inhibitors and combinations thereof for the treatment of urological disorders |
| 06/18/2008 | EP1931783A1 Chimeric hcn channels |
| 06/18/2008 | EP1931782A2 Methods for use in modulating mir-122a |
| 06/18/2008 | EP1931706A1 Collagen receptor i-domain binding modulators |
| 06/18/2008 | EP1931695A1 Prion-specific peptoid reagents |
| 06/18/2008 | EP1931694A1 Aptamers comprising arabinose modified nucleotides |
| 06/18/2008 | EP1931691A1 Odcase inhibitors for the treatment of malaria |
| 06/18/2008 | EP1931689A2 Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same |
| 06/18/2008 | EP1931683A1 Fused tricyclic mglur1 antagonists as therapeutic agents |
| 06/18/2008 | EP1931680A1 Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists |
| 06/18/2008 | EP1931679A1 Analogs of salinosporamide a |
| 06/18/2008 | EP1931678A1 Novel 6-amino-morphinan derivatives, method of manufacturing them and their application as analgesics |
| 06/18/2008 | EP1931677A2 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 06/18/2008 | EP1931676A1 Pyrazolopyrimidines as protein kinase inhibitors |
| 06/18/2008 | EP1931675A2 Pyrazolo(1, 5a) pyrimidines as protein kinase inhibitors |
| 06/18/2008 | EP1931674A2 Deazapurines useful as inhibitors of janus kinases |
| 06/18/2008 | EP1931672A1 Novel 5,6-dihydropyrazolo[3,4-e] [l,4]diazepin-4 (ih) -one derivatives for the treatment of asthma and chronic obstructive pulmonary disease. |
| 06/18/2008 | EP1931671A1 Alkyl 4- [4- (5-oxo-2, 3, 5, 11a-tetrahyd0-5h-pyrr0l0 [2, 1-c][1, 4]benzodiazepine-8-yloxy) -butyrylamino]-1h-pyrrole-2-carboxylate derivatives and related compounds for the treatment of a proliferative disease |
| 06/18/2008 | EP1931670A1 Pyridopyrimidinone inhibitors of pi3k |
| 06/18/2008 | EP1931669A1 Kinase inhibitors |
| 06/18/2008 | EP1931668A2 Substituted pyrazolo [3,4-b]pyridines as phosphodiesterase inhibitors |
| 06/18/2008 | EP1931667A1 Pyrido-pyridimidine derivatives useful as antiinflammatory agents |
| 06/18/2008 | EP1931666A1 Imidazopyridine derivatives as a2b adenosine receptor antagonists |
| 06/18/2008 | EP1931665A1 1-[[1-[(2-amin0-6-methyl-4-pyridinyl)methyl]-4-flu0r0-4-piperidinyl,]carbonyl]-4-[2-(2-pyridinyl)-3h-imidaz0[4, 5-b]pyridin-3-yl]piperidine useful as histamine h3 antagonist |
| 06/18/2008 | EP1931664A2 Methods of modulating neurotrophin-mediated activity |
| 06/18/2008 | EP1931663A1 Imdolizine derivatives as ligands of the crth2 receptor |
| 06/18/2008 | EP1931662A1 Pyrimidine derivatives for the inhibition of igf-ir tyrosine kinase activity |
| 06/18/2008 | EP1931661A1 Isoxazolo derivatives as gaba a alpha5 inverse agonists |
| 06/18/2008 | EP1931660A2 Phenyl-[1,2,4]-oxadiazol-5-one derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals |
| 06/18/2008 | EP1931659A1 Derivatives of 2 -aminthiazoles and 2-aminooxazoles, processes for their preparation and their use as pharmaceuticals |
| 06/18/2008 | EP1931658A2 1 , 4 and 1 , 5-disubstituted indole derivatives for use as ppar active compounds |
| 06/18/2008 | EP1931656A1 Novel drugs for dementia |
| 06/18/2008 | EP1931654A2 Modulators of metabolism and the treatment of disorders related thereto |
| 06/18/2008 | EP1931653A2 Therapeutic pyrrolidines |
| 06/18/2008 | EP1931651A1 Thiophene derivatives for the treatment of diabetes |
| 06/18/2008 | EP1931645A2 N- (3-amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors |
| 06/18/2008 | EP1931641A2 NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1,5-a]PYRIDINES, PYRAZOLO[1,5-c]PYRIMIDINES AND 2H-INDAZOLE COMPOUNDS AND 5-CYANO, 5-AMINO, AND 5-AMINOMETHYL DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINES, AND IMIDAZO[1,5-a]PYRAZINES COMPOUNDS AS CYCLIN DEPENDENT KINASE INHI |
| 06/18/2008 | EP1931640A2 Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 06/18/2008 | EP1931638A1 Process for the synthesis of compounds for selectin inhibition |
| 06/18/2008 | EP1931637A2 Methods of modulating neurotrophin-mediated activity |
| 06/18/2008 | EP1931636A1 Isoquinolines as igf-1r inhibitors |
| 06/18/2008 | EP1931635A1 Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors |
| 06/18/2008 | EP1931633A2 Derivatives of 3-azabicyclo[3.1.0]hexane as dipeptidyl peptidase-iv inhibitors |
| 06/18/2008 | EP1931632A2 Useful indole compounds |
| 06/18/2008 | EP1931631A1 1- (1h- indol- 1-yl) -3- (methylamino) -1- phenylpropan-2-ol derivatives and related compounds as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms) |
| 06/18/2008 | EP1931627A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands |
| 06/18/2008 | EP1931624A1 Use of an aureolysin inhibitor for the treatment of inflammatory skin conditions characterised by colonisation with staphylococcus aureus |
| 06/18/2008 | EP1931620A1 Amino-alkyl-amide derivatives as ccr3 receptor liquids |
| 06/18/2008 | EP1931425A1 Antituberculous composition comprising oxazole compounds |
| 06/18/2008 | EP1931424A2 P13k inhibitors for the treatment of endometriosis |
| 06/18/2008 | EP1931394A2 Apoe4 domain interaction inhibitors and methods of use thereof |
| 06/18/2008 | EP1931388A2 Methods for treatment and prevention of otitis media using nonionic surfactants to facilitate transmembrane drug delivery into the middle ear |
| 06/18/2008 | EP1931385A2 (s)-6-methyloxaalkyl exemestane compounds and related methods of use |
| 06/18/2008 | EP1931375A2 Chemo-immunotherapy method |
| 06/18/2008 | EP1931362A2 Drug delivery system for topical administration |
| 06/18/2008 | EP1931361A2 Nanosized carotenoid cyclodextrin complexes |
| 06/18/2008 | EP1931359A2 Combination therapy for controlled carbohydrate digestion |
| 06/18/2008 | EP1931358A1 Pharmaceutical combinations containing lamivudine, stavudine and nevirapine |
| 06/18/2008 | EP1931357A2 Prodrugs of phentermine |
| 06/18/2008 | EP1931356A2 Butyric acid ester of carbohydrates and carbohydrate polyols |
| 06/18/2008 | EP1931355A2 Methods for reducing platelet activation and for the treatment of thrombotic events |
| 06/18/2008 | EP1931354A2 Balsalazide formulations and manufacture and use thereof |
| 06/18/2008 | EP1931353A2 Osteogenic and anti-adiogenic oxysterols |
| 06/18/2008 | EP1931352A2 Tlr agonists |
| 06/18/2008 | EP1931350A2 Administration of dipeptidyl peptidase inhibitors |
| 06/18/2008 | EP1931349A2 Use of sodium channel blockers for the management of musculoskeletal pain |
| 06/18/2008 | EP1931348A2 Monocyclic and bicyclic compounds and methods of use |
| 06/18/2008 | EP1931347A2 Piperazine derivatives |
| 06/18/2008 | EP1931346A2 Trazodone composition for once a day adminisitiation |
| 06/18/2008 | EP1931345A2 Methods for treatment of thiol-containing compound deficient conditions |
| 06/18/2008 | EP1931343A2 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias |
| 06/18/2008 | EP1931342A2 Anesthesia induction and maintenance drug |
| 06/18/2008 | EP1931341A2 Novel 1h-indole-pyridinecarboxamide derivatives and 1h-indole-piperidinecarboxamide and their use as hydroxalase tyrosine inducers |
| 06/18/2008 | EP1931340A2 Nanoparticulate azelnidipine formulations |
| 06/18/2008 | EP1931339A1 Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer |
| 06/18/2008 | EP1931338A1 Aerosol powder formulation comprising sieved lactose |
| 06/18/2008 | EP1931337A2 Phenyl- and pyridinyl- 1, 2 , 4 - oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals |
| 06/18/2008 | EP1931336A1 Tetrahydro-indazolyl cannabinoid modulators |
| 06/18/2008 | EP1931335A1 Hexahydro cyclooctyl pyrazole cannabinoid modulators |
| 06/18/2008 | EP1931334A2 Functionalized drugs and polymers derived therefrom |
| 06/18/2008 | EP1931333A1 Amino acid and its uses |
| 06/18/2008 | EP1931332A2 Compounds and compositions to control abnormal cell growth |
| 06/18/2008 | EP1931331A1 Combinations comprising dmxaa for the treatment of cancer |
| 06/18/2008 | EP1931330A1 Composition comprising tanshinone compounds isolated from the extract of salviae miltiorrhizae radix for treating or preventing cognitive dysfunction and the use thereof |
| 06/18/2008 | EP1931329A1 Cosmetic compositions comprising hydroxyfatty acids |
| 06/18/2008 | EP1931328A2 Method of treating a subject suffering from degenerative disc disease using a nitric oxide synthase inhibitor |
| 06/18/2008 | EP1931326A1 Crystalline trihydrate of zoledronic acid |
| 06/18/2008 | EP1931324A2 Des-c,d analogs of 1alpha,25-dihydroxy-19-norvitamin d3 |
| 06/18/2008 | EP1931323A2 Formulations and methods for enhancing the transdermal penetration of a drug |
| 06/18/2008 | EP1931322A1 Ikk inhibitors for the treatment of endometriosis |
| 06/18/2008 | EP1931321A2 Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents |